Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis

Androgen receptor (AR) inhibition by androgen deprivation and/or antiandrogen administration is the mainstay therapy for advanced prostate cancer. However, most prostate cancers ultimately become resistant to these therapies, indicating the importance of identifying mechanisms driving resistance to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Rui, Yan, Binyuan, Li, Hao, Ding, Donglin, Wang, Liguo, Pang, Jun, Ye, Dingwei, Huang, Haojie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543964/
https://www.ncbi.nlm.nih.gov/pubmed/37527336
http://dx.doi.org/10.1158/0008-5472.CAN-23-0285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543964/
https://www.ncbi.nlm.nih.gov/pubmed/37527336
http://dx.doi.org/10.1158/0008-5472.CAN-23-0285

Ejemplares similares